Mechanisms of Regulation of Cannabinoid Disposition
大麻素处置的调节机制
基本信息
- 批准号:10231038
- 负责人:
- 金额:$ 41.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-09-01 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:Adverse effectsAffectAgeAge-YearsAnimal ModelBindingBinding ProteinsBiochemicalBiological MarkersBrainCYP2C9 geneCYP3A4 geneCannabinoidsCannabisCannabis AbuseCellsClinical ResearchCohort StudiesCollaborationsConsumptionCryopreservationDataDevelopmentDrug KineticsEnzyme InductionEnzymesEstradiolEstrogensEvaluationExposure toFamilyFemaleFetal DevelopmentFoundationsGlucocorticoidsGlucuronidesGoalsGut MucosaHepaticHepatocyteHormonesHumanHydrocortisoneIn VitroIndividualIntakeIntestinal MucosaIntestinesKnowledgeLiverMediatingMetabolicMetabolismMethodsMinorModelingMovementOutcomePharmacologyPlasmaPlayPregnancyPregnancy OutcomePregnant WomenProcessProtein IsoformsPublic HealthRegulationResearch PersonnelRiskRoleSeminalSerumSystemTHC exposureTechniquesTestingTetrahydrocannabinolTimeUGT1A1 geneUrineValidationWomanWorkbasecellular targetingdrug of abuseexperimental studyfatty acid-binding proteinsfetalfetal marijuana exposurein vivoinfant outcomeinnovationinter-individual variationintestinal fatty acid binding proteinmarijuana legalizationmarijuana usemetabolomenovelphysiologically based pharmacokineticspredictive modelingprenatal exposurereproductiveresponsesimulation
项目摘要
Cannabis is the most commonly used illicit substance in the world, and the use of cannabis by pregnant
women is increasing. Approximately 4% of all pregnant women use cannabis despite studies suggesting that
cannabis exposure during pregnancy has negative consequences to the developing fetus. This is a significant
public health concern. However, delineating the impact of cannabis use on pregnancy outcomes has suffered
from lack of understanding of how the pharmacokinetics of the active component of cannabis, ∆9-
tetrahydrocannabinol (THC) is altered during pregnancy, and from lack of a reliable biomarker to quantify
cannabis usage and exposure levels. In fact, at present the knowledge of processes that drive inter-individual
variability in THC disposition are largely unknown. Existing data suggests that THC is mainly cleared by
CYP2C9 with a minor contribution from CYP3A4. Several studies have shown that the elimination of the major
metabolites of THC, 11-OH-THC and 11-nor-carboxy-THC is mediated by UGT1A enzymes. This is important
in the context of THC disposition in pregnant women as CYP2C9 and UGT1A enzymes have been shown to
be regulated by estradiol and glucocorticoids, major female hormones that are increased during pregnancy.
Based on this data, we hypothesize that the clearance of THC and its metabolites is significantly increased
with increasing estradiol and glucocorticoid concentrations. We propose that this increase can be
mechanistically predicted from in vitro human hepatocyte and primary intestinal mucosal culture experiments
with hormone treatments and innovative THC metabolism experiments. In the first part of this project we will
test these hypotheses by determining the magnitude of changes in THC metabolism and in CYP2C9, CYP3A4
and UGT1A isoform expression following treatment of human hepatocytes and cryopreserved intestinal
mucosa with estradiol and glucocorticoids. We will also establish how hepatic and intestinal fatty acid binding
proteins (FABPs) affect the metabolism and distribution of THC and its metabolites in vitro. THC has been
shown to bind to brain FABPs, but whether THC and its metabolites bind to liver and intestinal FABPs is
unknown. We hypothesize that FABP binding directs THC metabolism, and contributes to cannabinoid
clearance and delivery to metabolic enzymes. We will test this innovative hypothesis in vitro using biochemical
methods. In the second part of this proposal, we will test in a clinical study whether estrogens and cortisol
induce THC metabolism and exposure. We expect that these studies will form the foundation for overall
prediction and modeling of THC disposition during human pregnancy. When completed, our studies will
provide critical information of the processes that contribute to inter-individual variability of THC
pharmacokinetics. These studies will also provide seminal data to allow modeling of THC metabolome in
human plasma and urine as a function of THC consumption and time after consumption, making a significant
impact on development of reliable biomarkers of THC exposures in humans.
大麻是世界上最常用的非法物质,孕妇使用大麻
妇女正在增加。大约4%的孕妇都使用大麻欲望研究,表明
怀孕期间的大麻暴露对发育中的胎儿会产生负面影响。这是重要的
公共卫生问题。但是,描述使用大麻对怀孕结果的影响已经遭受
由于缺乏对大麻活性成分的药代动力学的了解,∆9--
四氢大麻酚(THC)在怀孕期间发生了变化,并且由于缺乏可靠的生物标志物来量化
大麻使用和暴露水平。实际上,目前对驱动个人间个体的过程的知识
THC处置的可变性在很大程度上未知。现有数据表明,THC主要由
CYP2C9的CYP3A4贡献很小。几项研究表明,消除了主要
THC,11-OH-THC和11-NOR-羧基THC的代谢产物由UGT1A酶介导。这很重要
在孕妇的THC处置性的背景下,CYP2C9和UGT1A酶已显示为
受雌二醇和糖皮质激素的调节,这是妊娠期间增加的主要雌性骑兵。
基于这些数据,我们假设THC及其代谢物的清除率显着增加
随着雌二醇和糖皮质激素浓度的增加。我们建议这种增加可以是
从体外人类肝细胞和原发性肠粘膜培养实验中预测的机理预测
进行马匹治疗和创新的THC代谢实验。在这个项目的第一部分中,我们将
通过确定THC代谢和CYP2C9的变化的幅度来检验这些假设
治疗人肝细胞和冷冻保存肠后,UGT1A同工型表达
粘膜含有雌二醇和糖皮质激素。我们还将建立肝脂肪酸的结合
蛋白质(FABP)在体外影响THC及其代谢物的代谢和分布。 THC一直在
显示与脑Fabps结合,但是THC及其代谢物是否与肝脏和肠Fabps结合
未知。我们假设FABP结合指导THC代谢,并有助于大麻素
清除和向代谢酶递送。我们将在体外使用生化测试这种创新的假设
方法。在该提案的第二部分中,我们将在临床研究中测试雌激素和皮质醇是否
诱导THC代谢和暴露。我们希望这些研究将构成整体的基础
人类怀孕期间THC处置的预测和建模。完成后,我们的学习将
提供有助于THC的个体变异性的过程的关键信息
药代动力学。这些研究还将提供第二个数据,以允许对THC代谢组进行建模
人类血浆和尿液作为消费量和消费后的时间的函数
影响人类THC暴露的可靠生物标志物的发展。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Nina Isoherranen其他文献
Nina Isoherranen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Nina Isoherranen', 18)}}的其他基金
Identification and quantification of drug-protein adducts by mass spectrometry
通过质谱法鉴定和定量药物-蛋白质加合物
- 批准号:
10687252 - 财政年份:2022
- 资助金额:
$ 41.6万 - 项目类别:
Identification and quantification of drug-protein adducts by mass spectrometry
通过质谱法鉴定和定量药物-蛋白质加合物
- 批准号:
10537373 - 财政年份:2022
- 资助金额:
$ 41.6万 - 项目类别:
Mechanisms of regulation of retinoic acid homeostasis
视黄酸稳态的调节机制
- 批准号:
9274809 - 财政年份:2014
- 资助金额:
$ 41.6万 - 项目类别:
Mechanisms of Regulation of Retinoic Acid Homeostasis
视黄酸稳态的调节机制
- 批准号:
9975196 - 财政年份:2014
- 资助金额:
$ 41.6万 - 项目类别:
Mechanisms of regulation of retinoic acid homeostasis
视黄酸稳态的调节机制
- 批准号:
8918695 - 财政年份:2014
- 资助金额:
$ 41.6万 - 项目类别:
Mechanisms of regulation of retinoic acid homeostasis
视黄酸稳态的调节机制
- 批准号:
8764616 - 财政年份:2014
- 资助金额:
$ 41.6万 - 项目类别:
Mechanisms of regulation of retinoic acid homeostasis
视黄酸稳态的调节机制
- 批准号:
9102176 - 财政年份:2014
- 资助金额:
$ 41.6万 - 项目类别:
Mechanisms of regulation of retinoic acid homeostasis
视黄酸稳态的调节机制
- 批准号:
9300950 - 财政年份:2014
- 资助金额:
$ 41.6万 - 项目类别:
Mechanisms of Regulation of Cannabinoid Disposition
大麻素处置的调节机制
- 批准号:
10463602 - 财政年份:2013
- 资助金额:
$ 41.6万 - 项目类别:
Mechanisms of Regulation of Cannabinoid Disposition
大麻素处置的调节机制
- 批准号:
10688218 - 财政年份:2013
- 资助金额:
$ 41.6万 - 项目类别:
相似国自然基金
多氯联苯与机体交互作用对生物学年龄的影响及在衰老中的作用机制
- 批准号:82373667
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
恒星模型中氧元素丰度的变化对大样本F、G、K矮星年龄测定的影响
- 批准号:12303035
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
基于年龄和空间的非随机混合对性传播感染影响的建模与研究
- 批准号:12301629
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
母传抗体水平和疫苗初种年龄对儿童麻疹特异性抗体动态变化的影响
- 批准号:82304205
- 批准年份:2023
- 资助金额:20 万元
- 项目类别:青年科学基金项目
中国东部地区大气颗粒物的年龄分布特征及其影响因素的模拟研究
- 批准号:42305193
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
相似海外基金
Executive functions in urban Hispanic/Latino youth: exposure to mixture of arsenic and pesticides during childhood
城市西班牙裔/拉丁裔青年的执行功能:童年时期接触砷和农药的混合物
- 批准号:
10751106 - 财政年份:2024
- 资助金额:
$ 41.6万 - 项目类别:
Maternal inflammation in relation to offspring epigenetic aging and neurodevelopment
与后代表观遗传衰老和神经发育相关的母体炎症
- 批准号:
10637981 - 财政年份:2023
- 资助金额:
$ 41.6万 - 项目类别:
Impact of Body Composition and Related Inflammatory and Immune States on Prognosis of Non-Muscle Invasive Bladder Cancer
身体成分及相关炎症和免疫状态对非肌肉浸润性膀胱癌预后的影响
- 批准号:
10674401 - 财政年份:2023
- 资助金额:
$ 41.6万 - 项目类别:
The Role of Outpatient Diuretic Therapy in Bronchopulmonary Dysplasia
门诊利尿疗法在支气管肺发育不良中的作用
- 批准号:
10663469 - 财政年份:2023
- 资助金额:
$ 41.6万 - 项目类别:
Preclinical testing of early life anti-myostatin therapy for osteogenesis imperfecta
早期抗肌生长抑制素治疗成骨不全症的临床前测试
- 批准号:
10840238 - 财政年份:2023
- 资助金额:
$ 41.6万 - 项目类别: